Equities

Haba Laboratories Inc

4925:TYO

Haba Laboratories Inc

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)2,081.00
  • Today's Change-14.00 / -0.67%
  • Shares traded400.00
  • 1 Year change-10.73%
  • Beta0.8902
Data delayed at least 20 minutes, as of May 31 2024 06:03 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.

  • Revenue in JPY (TTM)12.32bn
  • Net income in JPY-2.12bn
  • Incorporated1976
  • Employees654.00
  • Location
    Haba Laboratories Inc1-24-11, Kanda Suda-choCHIYODA-KU 101-0041JapanJPN
  • Phone+81 352966250
  • Fax+81 352966267
  • Websitehttp://www.haba.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Soiken Holdings Inc5.34bn-618.91m4.26bn98.00--0.6746--0.7992-23.66-23.66203.95241.630.68152.506.8454,438,810.00-7.928.75-9.2710.9046.7746.98-11.627.338.97--0.0020.19-13.568.17-44.2017.941.6720.11
NANSIN CO., LTD.8.92bn155.81m4.39bn427.0024.480.332212.800.494523.3623.361,334.381,721.680.56061.934.69--0.97972.261.252.8324.2125.331.753.792.3028.070.143835.04-9.10-1.17-73.74-23.165.9714.87
ATOM LIVIN TECH Co., Ltd.10.28bn259.91m5.60bn126.0020.920.536812.610.544565.1665.162,576.222,539.070.776812.674.1181,559,780.001.963.442.534.3624.7327.422.534.152.56--0.0032.034.25-0.1299-15.84-4.94-18.801.92
C'BON COSMETICS Co Ltd8.50bn-26.35m5.97bn737.00--1.0656.830.7027-6.16-6.161,985.491,322.240.96322.2410.13---0.2986-4.32-0.4286-5.5475.3076.20-0.31-4.521.71--0.0008---0.3103-7.4993.75--15.74-17.81
Adjuvant Holdings Co Ltd4.44bn-99.87m6.83bn134.00--1.62270.331.55-12.50-12.50555.06527.070.81971.4210.62---1.842.25-2.082.5864.4563.70-2.252.684.26--0.0073141.261.39-2.98-124.74---30.17-12.94
Premier Antiaging Co Ltd22.79bn-2.39bn7.05bn252.00--1.21--0.3141-274.41-274.412,613.53679.211.872.1810.6090,440,270.00-19.6511.40-27.7420.0272.6878.45-10.503.822.02--0.27350.00-22.1539.62-151.53--78.15--
Shobido Corp21.03bn676.06m7.15bn232.0010.711.078.070.349451.1851.181,592.22511.631.357.585.7090,658,600.004.392.107.083.2126.0427.943.261.751.67--0.466552.9518.312.94-7.1137.80-3.8611.20
Iwabuchi Corp11.77bn674.29m7.63bn451.0011.050.399110.270.6487628.25628.2510,965.9117,390.390.48252.913.65--2.823.153.303.6730.0928.525.836.473.90--0.047432.136.193.60-14.1635.705.191.92
Oizumi Corp21.39bn528.95m7.76bn421.0014.930.43025.900.369223.5123.51951.00816.000.49952.704.99--1.242.411.623.0633.2730.972.476.031.5713.630.4925.3318.0117.08-65.06-2.43-16.075.92
Path Corp2.32bn-175.88m8.22bn56.00--6.61--3.57-3.31-3.3143.6521.321.481.689.02---11.25-34.74-15.11-56.3647.4550.26-7.58-22.511.27------16.47-8.8131.33--4.73--
HABA LABORATORIES, INC.12.32bn-2.12bn8.24bn654.00--0.925--0.6644-560.26-560.263,259.062,249.650.911.1111.04---15.64-1.97-19.73-2.4568.1970.38-17.19-2.241.91-18.910.2168--2.38-8.54-199.30---1.730.00
Niitaka Co., Ltd22.18bn449.37m11.24bn394.0024.900.858210.850.507976.1176.113,756.252,208.011.027.595.0256,282,800.002.104.552.775.9535.1240.372.074.811.98--0.173822.969.623.12-54.40-6.50-30.2821.67
CB Group Management Co Ltd147.28bn2.06bn12.05bn647.005.160.43014.700.0823954.40954.4068,339.4511,451.812.9115.836.37--4.072.537.865.2911.2311.581.400.85141.17--0.108416.116.150.196224.8926.22-10.904.56
Data as of May 31 2024. Currency figures normalised to Haba Laboratories Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

1.25%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 31 Mar 202425.00k0.64%
Daiwa Asset Management Co. Ltd.as of 17 Mar 202320.70k0.53%
Niche Asset Management Ltd.as of 30 Jun 20231.20k0.03%
Mitsubishi UFJ Asset Management Co., Ltd.as of 16 Sep 20221.00k0.03%
Dimensional Fund Advisors Ltd.as of 31 Mar 2024900.000.02%
DFA Australia Ltd.as of 31 May 2023299.000.01%
Samarang LLPas of 30 Jun 20220.000.00%
More ▼
Data from 30 Jun 2022 - 23 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.